Publications by authors named "Peter Myler"

Article Synopsis
  • Helicobacter pylori is a type 1 carcinogen linked to gastric ulcers and cancer, and research by the Seattle Structural Genomics Center for Infectious Disease focuses on potential treatments targeting this bacterium.
  • The study reports on the purification and crystallization of H. pylori biotin protein ligase (HpBPL), an enzyme that plays a crucial role in important metabolic processes and helps H. pylori thrive in the acidic environment of the stomach.
  • Despite having low sequence identity with similar proteins, HpBPL shares significant structural similarities with Mycobacterium tuberculosis biotin protein ligase, indicating potential for developing inhibitors that could be effective against HpBPL.
View Article and Find Full Text PDF

Plasmodium vivax, a significant contributor to global malaria cases, poses an escalating health burden on a substantial portion of the world's population. The increasing spread of P. vivax because of climate change underscores the development of new and rational drug-discovery approaches.

View Article and Find Full Text PDF

Griselimycin, a cyclic depsidecapeptide produced by Streptomyces griseus, is a promising lead inhibitor of the sliding clamp component of bacterial DNA polymerases (β-subunit of Escherichia coli DNA pol III). It was previously shown to inhibit the Mycobacterium tuberculosis β-clamp with remarkably high affinity and selectivity - the peptide lacks any interaction with the human sliding clamp. Here, we used a structural genomics approach to address the prospect of broader-spectrum inhibition, in particular of β-clamps from Gram-negative bacterial targets.

View Article and Find Full Text PDF
Article Synopsis
  • Trichomonas vaginalis is a one-celled parasite that causes trichomoniasis, the most common nonviral STD worldwide, and it uses mimicry of human proteins to evade the immune system.
  • The parasite produces a protein called TvMIF, which helps it survive stress, boosts prostate cell growth, and triggers inflammation, paralleling the effects of human MIF.
  • Recent studies have revealed the structure of TvMIF, showing it has a similar shape to human versions, suggesting that understanding this protein can aid in developing new drugs.
View Article and Find Full Text PDF
Article Synopsis
  • * There is a growing need for alternative treatments due to drug resistance in H. pylori, leading to research at the Seattle Structural Genomics Center for Infectious Disease (SSGCID) into potential drug targets, specifically Glutamyl-tRNA synthetase (GluRS).
  • * The SSGCID has successfully determined the structure of H. pylori GluRS, which shares significant similarities with other bacterial GluRS, presenting opportunities for drug discovery aimed at developing new antibacterials to combat H. pylori infections.
View Article and Find Full Text PDF
Article Synopsis
  • Onchocerca volvulus is responsible for serious health issues, including blindness and neurological diseases, and current treatments like ivermectin can't be safely used in pregnant women or those co-infected with Loa loa.
  • Researchers at the Seattle Structural Genomics Center for Infectious Disease have successfully produced and crystallized a potential drug target called OvMIF-1, which has a unique jellyfish-like structure.
  • The study suggests that deleting its N-terminal tag could reveal a larger cavity for drug targeting, indicating the need for further analysis to confirm the true biological structure of OvMIF-1.
View Article and Find Full Text PDF
Article Synopsis
  • Plasmodium vivax causes malaria, affecting about a third of the world's population, and primaquine treatment is unsafe for those with G6PD deficiency, which impacts a significant portion of people in endemic areas.
  • The Seattle Structural Genomics Center for Infectious Disease studied PvNMT (N-myristoyltransferase) to find alternative drug targets since it's essential for P. vivax survival by facilitating protein modification.
  • The newly solved crystal structure of PvNMT, showing its interaction with myristoyl-CoA and a novel inhibitor, reveals differences from human enzymes, providing insights for creating effective antimalarial drugs.
View Article and Find Full Text PDF
Article Synopsis
  • Brucella ovis is a major cause of reproductive diseases in sheep and other animals, with no effective global eradication methods for ovine brucellosis currently available.
  • Research at the Seattle Structural Genomics Center is focusing on analyzing B. ovis and other Brucella proteins to discover new therapeutic targets while also aiding in education about structural science and biochemistry.
  • The study highlights the unique structure of BoLBP, a protein that binds amino acids, which could help in the development of new drugs by revealing insights into its flexibility and potential for drug repurposing.
View Article and Find Full Text PDF
Article Synopsis
  • Klebsiella pneumoniae (Kp) is a major global health concern due to its ability to cause severe infections and resist multiple drugs, making research on its enzymes crucial for developing effective antibiotics like nitrofurantoin.
  • This study presents crystal structures of two Kp nitroreductases (Kp-NRs) at high resolutions, detailing their unique structural features, including their αβ folds and variations in specific loops.
  • The findings suggest that these enzymes may play a role in detoxifying harmful compounds and activating nitrofuran drugs, indicating their potential significance in combating Kp infections.
View Article and Find Full Text PDF

-myristoyltransferase (NMT) is a promising antimalarial drug target. Despite biochemical similarities between and human NMTs, our recent research demonstrated that high selectivity is achievable. Herein, we report NMT-inhibiting compounds aimed at identifying novel mechanisms of selectivity.

View Article and Find Full Text PDF

The rise in antimicrobial resistance is a global health crisis and necessitates the development of novel strategies to treat infections. For example, in 2022 tuberculosis (TB) was the second leading infectious killer after COVID-19, with multi-drug-resistant strains of TB having an ∼40% fatality rate. Targeting essential biosynthetic pathways in pathogens has proven to be successful for the development of novel antimicrobial treatments.

View Article and Find Full Text PDF

Parasitic protozoa of the genus Leishmania cycle between the phagolysosome of mammalian macrophages, where they reside as rounded intracellular amastigotes, and the midgut of female sand flies, which they colonize as elongated extracellular promastigotes. Previous studies indicated that protein kinase A (PKA) plays an important role in the initial steps of promastigote differentiation into amastigotes. Here, we describe a novel regulatory subunit of PKA (which we have named PKAR3) that is unique to Leishmania and most (but not all) other Kinetoplastidae.

View Article and Find Full Text PDF

The methylerythritol phosphate (MEP) pathway is a metabolic pathway that produces the isoprenoids isopentyl pyrophosphate and dimethylallyl pyrophosphate. Notably, the MEP pathway is present in bacteria and not in mammals, which makes the enzymes of the MEP pathway attractive targets for discovering new anti-infective agents due to the reduced chances of off-target interactions leading to side effects. There are seven enzymes in the MEP pathway, the third of which is IspD.

View Article and Find Full Text PDF

Interactions between DNA aptamers and protein targets hold promise for the development of pharmaceuticals and diagnostics. As such, the utilization of fluorescent nucleobase surrogates in studying aptamer-protein interactions is a powerful tool due to their ability to provide site-specific information through turn-on fluorescence. Unfortunately, previously described turn-on probes serving as nucleobase replacements have only been strongly disruptive to the affinity of aptamer-protein interactions.

View Article and Find Full Text PDF

Research directed at select prototype pathogens is part of the approach put forth by the National Institute of Allergy and Infectious Disease (NIAID) to prepare for future pandemics caused by emerging viruses. We were tasked with identifying suitable prototypes for four virus families of the Bunyavirales order (Phenuiviridae, Peribunyaviridae, Nairoviridae, and Hantaviridae). This is a challenge due to the breadth and diversity of these viral groups.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic free-living amoebae (pFLA) pose serious risks for central nervous system infections, making it crucial to find new chemical agents to fight these pathogens.
  • The study focuses on glucokinase (Glck), a metabolic enzyme with minimal similarity to human counterparts, as a promising target for developing inhibitors.
  • Using a novel "shotgun" multifragment kinetic target-guided synthesis (KTGS) strategy, researchers identified 12 effective inhibitors against three different pFLA glucokinase enzymes, showcasing KTGS's effectiveness even in the absence of detailed structural information.
View Article and Find Full Text PDF
Article Synopsis
  • * Inorganic pyrophosphatases (PPases) break down PP into orthophosphates, preventing toxic buildup and providing usable phosphate for biosynthesis.
  • * The study reports a crystal structure of L. pneumophila's family I PPase at high resolution, revealing its hexameric structure and preference for Mg as a cofactor, which is significant due to the bacterium's link to Legionnaires' disease.
View Article and Find Full Text PDF
Article Synopsis
  • Around 50,000 children under 5 die annually from diarrhea caused by a protozoan parasite, with no effective drugs or vaccines currently available.
  • Researchers conducted a high throughput screening (HTS) of compounds to find potential drugs targeting a protein called N-myristoyltransferase (NMT), which is a validated target in similar parasites.
  • Two promising compounds were identified and tested against NMT, revealing different binding site conformations that offer insight for designing new selective inhibitors.
View Article and Find Full Text PDF

Drugs targeting multiple stages of the Plasmodium vivax life cycle are needed to reduce the health and economic burdens caused by malaria worldwide. N-myristoyltransferase (NMT) is an essential eukaryotic enzyme and a validated drug target for combating malaria. However, previous PvNMT inhibitors have failed due to their low selectivity over human NMTs.

View Article and Find Full Text PDF

Because purine nucleotides are essential for all life, differences between how microbes and humans metabolize purines can be exploited for the development of antimicrobial therapies. While humans biosynthesize purine nucleotides in a 10-step pathway, most microbes utilize an additional 11th enzymatic activity. The human enzyme, aminoimidazole ribonucleotide (AIR) carboxylase generates the product 4-carboxy-5-aminoimidazole ribonucleotide (CAIR) directly.

View Article and Find Full Text PDF

Human infection with the protozoan parasite Trypanosoma cruzi causes Chagas disease for which there are no prophylactic vaccines. Cyclophilin 19 is a secreted cis-trans peptidyl isomerase expressed in all life stages of Trypanosoma cruzi. This protein in the insect stage leads to the inactivation of insect anti-parasitic peptides and parasite transformation whereas in the intracellular amastigotes it participates in generating ROS promoting the growth of parasites.

View Article and Find Full Text PDF

This review presents a comprehensive overview of transition-metal-catalyzed domino reactions of strained bicyclic alkenes, including both homo- and heterobicyclic alkenes. These compounds are important synthons in organic synthesis, providing an important platform for the construction of biologically/medicinally significant compounds which bear multiple stereocenters. The review has been divided according to the metal used in the reaction.

View Article and Find Full Text PDF

Euglenoids (Euglenida) are unicellular flagellates possessing exceptionally wide geographical and ecological distribution. Euglenoids combine a biotechnological potential with a unique position in the eukaryotic tree of life. In large part these microbes owe this success to diverse genetics including secondary endosymbiosis and likely additional sources of genes.

View Article and Find Full Text PDF

E-cadherin adhesion is regulated at the cell surface, a process that can be replicated by activating antibodies. We use cryo-electron microscopy (EM) and X-ray crystallography to examine functional states of the cadherin adhesive dimer. This dimer is mediated by N-terminal beta strand-swapping involving Trp2, and forms via a different transient X-dimer intermediate.

View Article and Find Full Text PDF

Eukaryotes use histone variants and post-translation modifications (PTMs), as well as DNA base modifications, to regulate DNA replication/repair, chromosome condensation, and gene expression. Despite the unusual organization of their protein-coding genes into large polycistronic transcription units (PTUs), trypanosomatid parasites also employ a "histone code" to control these processes, but the details of this epigenetic code are poorly understood. Here, we present the results of experiments designed to elucidate the distribution of histone variants and PTMs over the chromatin landscape of .

View Article and Find Full Text PDF